http://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.png00Kelly Southernhttp://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.pngKelly Southern2018-03-01 09:11:182018-03-01 09:11:56Mission Therapeutics Strengthens Senior Management Team with Appointment of Dr Paul Thompson, Vice President, Clinical Development
http://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.png00Kelly Southernhttp://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.pngKelly Southern2017-11-16 08:27:462017-11-16 08:30:16Mission Therapeutics’ Highlights Positive Parkinson’s Disease USP30 Target and Inhibitor Data at the Society for Neuroscience 2017 Annual Meeting
http://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.png00Kelly Southernhttp://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.pngKelly Southern2017-11-01 09:48:032017-11-01 09:53:54Mission Therapeutics’ Scientists Presenting Novel Parkinson’s USP30 Target and Inhibitor Data at the Society for Neuroscience 2017 Annual Meeting
http://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.png00Kelly Southernhttp://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.pngKelly Southern2017-10-30 13:03:222017-10-30 13:03:22Mission Therapeutics Presenting at The Michael J. Fox Foundation’s Parkinson’s Disease Therapeutics Conference
